Ontozry

Medicinal product

(Invented) name

Ontozry

Active substance (s)

Cenobamatas

Strength

200 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX25, cenobamate

Marketing authorisation holder

Angelini Pharma S.p.A., Italija

Date of authorisation

2021-03-26

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Cenobamatas	200 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
106316	92417	1092417	lizdinė plokštelė	N14		Receptinis	EU/1/21/1530/011	Netiekiama	-	-	No	-	-
106317	92418	1092418	lizdinė plokštelė	N28		Receptinis	EU/1/21/1530/012	Netiekiama	-	-	No	-	-
106318	92419	1092419	lizdinė plokštelė	N84		Receptinis	EU/1/21/1530/013	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-03-26	Registruotas